Comparing KORU Medical Systems (NASDAQ:KRMD) & MSP Recovery (NASDAQ:MSPR)

KORU Medical Systems (NASDAQ:KRMD) and MSP Recovery (NASDAQ:MSPR) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, valuation, profitability, earnings, dividends, analyst recommendations and institutional ownership.

Analyst Ratings

This is a breakdown of current recommendations for KORU Medical Systems and MSP Recovery, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
KORU Medical Systems	1	1	4	0	2.50
MSP Recovery	1	0	0	0	1.00

KORU Medical Systems presently has a consensus target price of $6.50, indicating a potential upside of 54.39%. Given KORU Medical Systems’ stronger consensus rating and higher probable upside, analysts clearly believe KORU Medical Systems is more favorable than MSP Recovery.

Risk & Volatility

KORU Medical Systems has a beta of 0.47, suggesting that its stock price is 53% less volatile than the S&P 500. Comparatively, MSP Recovery has a beta of -2.9, suggesting that its stock price is 390% less volatile than the S&P 500.

Earnings and Valuation

This table compares KORU Medical Systems and MSP Recovery”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
KORU Medical Systems	$41.13 million	4.75	-$2.64 million	($0.06)	-70.17
MSP Recovery	$9.81 million	0.05	-$360.50 million	($572.83)	0.00

KORU Medical Systems has higher revenue and earnings than MSP Recovery. KORU Medical Systems is trading at a lower price-to-earnings ratio than MSP Recovery, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares KORU Medical Systems and MSP Recovery’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
KORU Medical Systems	-6.41%	-15.90%	-9.77%
MSP Recovery	-7,328.48%	-326.80%	-81.27%

Insider & Institutional Ownership

58.6% of KORU Medical Systems shares are held by institutional investors. Comparatively, 3.8% of MSP Recovery shares are held by institutional investors. 20.6% of KORU Medical Systems shares are held by insiders. Comparatively, 50.5% of MSP Recovery shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

KORU Medical Systems beats MSP Recovery on 12 of the 14 factors compared between the two stocks.

About KORU Medical Systems

KORU Medical Systems, Inc. develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products. The company was incorporated in 1980 and is based in Mahwah, New Jersey.

About MSP Recovery

MSP Recovery, Inc. engages in the development of healthcare recoveries and data analytics software. It also focuses on the identification and recoveries of improper payments made by Medicare, Medicaid, and commercial insurance spaces using data and analytics. The company was founded by John H. Ruiz, Frank C. Quesada, and Diana Diaz on July 8, 2014 and is headquartered in Miami, FL.